203 related articles for article (PubMed ID: 12009904)
1. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Biochemistry; 2002 May; 41(20):6414-21. PubMed ID: 12009904
[TBL] [Abstract][Full Text] [Related]
2. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Carcinogenesis; 2002 Oct; 23(10):1721-7. PubMed ID: 12376482
[TBL] [Abstract][Full Text] [Related]
3. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
4. Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.
Torino JL; Burger MS; Reznikoff CA; Swaminathan S
Carcinogenesis; 2001 Jan; 22(1):147-54. PubMed ID: 11159753
[TBL] [Abstract][Full Text] [Related]
5. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
6. Human urinary bladder epithelial cells lacking wild-type p53 function are deficient in the repair of 4-aminobiphenyl-DNA adducts in genomic DNA.
Swaminathan S; Torino JL; Burger MS
Mutat Res; 2002 Jan; 499(1):103-17. PubMed ID: 11804609
[TBL] [Abstract][Full Text] [Related]
7. Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32P-postlabeling method.
Swaminathan S; Hatcher JF
Chem Biol Interact; 2002 Feb; 139(2):199-213. PubMed ID: 11823007
[TBL] [Abstract][Full Text] [Related]
8. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma.
Hu W; Feng Z; Eveleigh J; Iyer G; Pan J; Amin S; Chung FL; Tang MS
Carcinogenesis; 2002 Nov; 23(11):1781-9. PubMed ID: 12419825
[TBL] [Abstract][Full Text] [Related]
9. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene.
Tang MS; Zheng JB; Denissenko MF; Pfeifer GP; Zheng Y
Carcinogenesis; 1999 Jun; 20(6):1085-9. PubMed ID: 10357792
[TBL] [Abstract][Full Text] [Related]
10. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.
Romano G; Garagnani L; Boninsegna A; Ferrari P; Flamini G; De Gaetani C; Sgambato A; Giovanni F; Curigliano G; Ferretti G; Cittadini A; Trentini G
Anticancer Res; 1999; 19(5C):4571-6. PubMed ID: 10650812
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of N-hydroxy-4-aminobiphenyl in human TP53 knock-in (Hupki) mouse embryo fibroblasts.
Hölzl-Armstrong L; Kucab JE; Zwart EP; Luijten M; Phillips DH; Arlt VM
Environ Mol Mutagen; 2021 Apr; 62(4):252-264. PubMed ID: 33620775
[TBL] [Abstract][Full Text] [Related]
13. C5 cytosine methylation at CpG sites enhances sequence selectivity of mitomycin C-DNA bonding.
Li VS; Reed M; Zheng Y; Kohn H; Tang M
Biochemistry; 2000 Mar; 39(10):2612-8. PubMed ID: 10704210
[TBL] [Abstract][Full Text] [Related]
14. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
Chen JX; Zheng Y; West M; Tang MS
Cancer Res; 1998 May; 58(10):2070-5. PubMed ID: 9605744
[TBL] [Abstract][Full Text] [Related]
15. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
[TBL] [Abstract][Full Text] [Related]
16. Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites.
Arakawa H; Wu F; Costa M; Rom W; Tang MS
Carcinogenesis; 2006 Mar; 27(3):639-45. PubMed ID: 16251206
[TBL] [Abstract][Full Text] [Related]
17. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair.
Feng Z; Hu W; Hu Y; Tang MS
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15404-9. PubMed ID: 17030796
[TBL] [Abstract][Full Text] [Related]
18. Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells.
Frederickson SM; Hatcher JF; Reznikoff CA; Swaminathan S
Carcinogenesis; 1992 Jun; 13(6):955-61. PubMed ID: 1600616
[TBL] [Abstract][Full Text] [Related]
19. The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.
Glick J; Xiong W; Lin Y; Noronha AM; Wilds CJ; Vouros P
J Mass Spectrom; 2009 Aug; 44(8):1241-8. PubMed ID: 19536795
[TBL] [Abstract][Full Text] [Related]
20. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
